ACRAL LENTIGINOUS MELANOMA STAGE II

ACRAL LENTIGINOUS MELANOMA STAGE II was reported 5 times

ACRAL LENTIGINOUS MELANOMA STAGE II is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
1 Prostaglandin Analog [EPC] 1 0.0000
2 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
3 Alkylating Drug [EPC] 2 0.0000
4 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
5 Thalidomide Analog [EPC] 2 0.0000
6 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
7 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
8 Corticosteroid [EPC] 2 0.0000